Cargando…

Infliximab is a plausible alternative for neurologic complications of Behçet disease

OBJECTIVE: We evaluated the effectiveness of infliximab in patients with neuro-Behçet syndrome for whom other immunosuppressive medications had failed. METHODS: Patients whose common immunosuppressive medications fail in recurrent neuro-Behçet syndrome need an alternative. We report our experience w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeydan, Burcu, Uygunoglu, Ugur, Saip, Sabahattin, Demirci, Onat N., Seyahi, Emire, Ugurlu, Serdal, Hamuryudan, Vedat, Siva, Aksel, Kantarci, Orhun H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950829/ https://www.ncbi.nlm.nih.gov/pubmed/27458602 http://dx.doi.org/10.1212/NXI.0000000000000258

Ejemplares similares

A case of neurosarcoidosis with aggresive characteristics
por: Ugurlu, Serdal, et al.
Publicado: (2014)

Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine
por: Ozdede, Ayse, et al.
Publicado: (2022)

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
por: Avsar, Timucin, et al.
Publicado: (2015)

Secukinumab induced Behçet’s syndrome: a report of two cases
por: Dincses, Elif, et al.
Publicado: (2019)

Characteristics of optic neuropathy in Behçet disease
por: Akdal, Gülden, et al.
Publicado: (2018)

The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome
por: Ozcifci, Guzin, et al.
Publicado: (2021)

Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion
por: Ucar, Didar, et al.
Publicado: (2020)

Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients
por: Yurttaş, Berna, et al.
Publicado: (2020)

Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey
por: Yurttas, Berna, et al.
Publicado: (2021)

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers
por: Everest, Elif, et al.
Publicado: (2023)

Behçet’s Syndrome and Thrombosis
por: Seyahi, Emire, et al.
Publicado: (2011)

Behçet’s syndrome: providing integrated care
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2017)

The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey
por: Seyahi, Emire, et al.
Publicado: (2020)

Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey
por: Baykan, Betul, et al.
Publicado: (2015)

Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2020)

Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center
por: ÖZTAŞ, Mert, et al.
Publicado: (2021)

Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study
por: Seyahi, Emire, et al.
Publicado: (2015)

Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation
por: Everest, Elif, et al.
Publicado: (2022)

The validation of ID migraine™ screener in neurology outpatient clinics in Turkey
por: Karli, Necdet, et al.
Publicado: (2007)

Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
por: Ugurlu, Serdal, et al.
Publicado: (2017)

Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
por: Nathoo, Nabeela, et al.
Publicado: (2023)

Cervical spinal cord atrophy: An early marker of progressive MS onset
por: Zeydan, Burcu, et al.
Publicado: (2018)

Relapse recovery: The forgotten variable in multiple sclerosis clinical trials
por: Kantarci, Orhun H., et al.
Publicado: (2019)

Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women
por: Karlı, Necdet, et al.
Publicado: (2012)

The impact of depression and ghrelin on body weight in migraineurs
por: Turan, Bulent, et al.
Publicado: (2014)

Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
por: Seyahi, Emire, et al.
Publicado: (2021)

One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults
por: Ertas, Mustafa, et al.
Publicado: (2012)

EHMTI-0248. Evaluation of headache prevalence and characteristics in orphans aged 12-17
por: Senturk, A Ates, et al.
Publicado: (2014)

The Prevalence of Familial Mediterranean Fever and Behçet’s Disease: A Cross-Sectional Study
por: ALPARSLAN, Özgür, et al.
Publicado: (2020)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

Reproductive history and progressive multiple sclerosis risk in women
por: Zeydan, Burcu, et al.
Publicado: (2020)

Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome
por: Rival, Manon, et al.
Publicado: (2022)

Aortic Arch Aneurysm in Behçet Disease Successfully Treated with Infliximab
por: Nishiyama, Taihei, et al.
Publicado: (2020)

COVID-19 Among Patients With Inflammatory Rheumatic Diseases
por: Esatoglu, Sinem Nihal, et al.
Publicado: (2021)

The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report
por: Sahin, Ozlem G.
Publicado: (2011)

Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease
por: Ikewaki, Junko, et al.
Publicado: (2010)

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016)

Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration
por: Handa, Tsuneaki, et al.
Publicado: (2011)

Trabeculotomy in a Behçet's Disease Patient One Week after Infliximab Administration
por: Koike, Aya, et al.
Publicado: (2012)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_94hf3ugpca6hlc3t413q7pnpvq